Kidney Cancer
Cancer gene family member functions key to cell adhesion and migration
The WTX gene is mutated in approximately 30 percent of Wilms tumors, a pediatric kidney cancer. Like many genes, WTX is part of a family. In this case, WTX has two related siblings, FAM123A and FAM123C. While ...
Cancer
Aug 30, 2012 |
not rated yet |
0
|
Cancer therapy that boosts immune system ready for wider testing
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have ...
Cancer
Jun 02, 2012 |
4.6 / 5 (7) |
0
|
Scientists boost potency, reduce side effects of IL-2 protein used to treat cancer
The utility of a naturally occurring protein given, sometimes to great effect, as a drug to treat advanced cancers is limited by the severe side effects it sometimes causes. But a Stanford University School of Medicine scientist ...
Medical research
Mar 18, 2012 |
4.5 / 5 (2) |
0
|
Newly identified gene mutation adds to melanoma risk
A major international study has identified a novel gene mutation that appears to increase the risk of both inherited and sporadic cases of malignant melanoma, the most deadly form of skin cancer. The identified mutation occurs ...
Cancer
Nov 13, 2011 |
not rated yet |
0
|
New drug may help immune system fight cancer
(HealthDay)—An experimental drug that taps the power of the body's immune system to fight cancer is shrinking tumors in patients for whom other treatments have failed, an early study shows.
Cancer
May 16, 2013 |
5 / 5 (3) |
0
|
New kidney cancer subtypes discovered
Researchers with the Institute of Urologic Oncology and the Department of Urology at UCLA have classified kidney cancer into several unique subtypes, a finding that will help physicians tailor treatment to ...
Cancer
Apr 16, 2013 |
5 / 5 (1) |
0
|
Rice-cell cocktail kills cancer cells, leaves normal cells alone
(Medical Xpress)—Juice from rice cells knocked out two kinds of human cancer cells as well or better than the potent anti-cancer drug Taxol in lab tests conducted by a Michigan Technological University ...
Cancer
Jan 14, 2013 |
4.9 / 5 (8) |
0
|
FDA panel recommends against 1st drug for chronic fatigue syndrome
(HealthDay)—A U.S. Food and Drug Administration advisory committee on Thursday recommended against approval of the first proposed drug to treat chronic fatigue syndrome.
Medications
Dec 21, 2012 |
1 / 5 (1) |
1
|
Avastin won't extend breast cancer survival: study
(HealthDay)—The drug Avastin (bevacizumab), when added to chemotherapy, does not improve disease-free survival in patients with triple-negative breast cancer any better than chemo alone, new research finds.
Medications
Dec 07, 2012 |
not rated yet |
0
|
Thalidomide relieves disabling cough for people with deadly lung disease, study shows
In the first clinical trial to demonstrate an effective treatment for constant, disabling cough among people with idiopathic pulmonary fibrosis (IPF), researchers at the Johns Hopkins University School of Medicine found that ...
Diseases, Conditions, Syndromes
Sep 17, 2012 |
not rated yet |
0
|
Depression could shorten cancer survival, study suggests
(HealthDay) -- Symptoms of depression are linked to shorter survival times among cancer patients, according to a new study.
Cancer
Aug 02, 2012 |
not rated yet |
0
|
New vaccine for renal cell carcinoma found to increase survival rates
(Medical Xpress) -- Researchers working for German pharmaceutical company Immatics Biotechnologies GmbH, have outlined two successful outcomes for their multipeptide vaccine IMA901 in a paper they’ve had published in ...
Cancer
Jul 30, 2012 |
not rated yet |
1
|
'Molecular grenade': Drug from Mediterranean weed kills tumor cells in mice
Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel -- undetected by normal cells -- through the bloodstream until activated by ...
Cancer
Jul 09, 2012 |
5 / 5 (18) |
2
|
How a quirky fruit fly gene could help researchers develop new cancer drugs
(Medical Xpress) -- Loyola researchers are taking advantage of a quirk in the evolution of fruit fly genes to help develop new weapons against cancer.
Genetics
Jun 14, 2012 |
5 / 5 (1) |
0
|
Folic acid may reduce some childhood cancers
Folic acid fortification of foods may reduce the incidence of the most common type of kidney cancer and a type of brain tumors in children, finds a new study by Kimberly J. Johnson, PhD, assistant professor at the Brown School ...
Pediatrics
May 21, 2012 |
not rated yet |
0
|
Kidney cancer is a type of cancer that starts in the cells in the kidney.
The two most common types of kidney cancer are renal cell carcinoma (RCC) and urothelial cell carcinoma (UCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed.
The different types of kidney cancer (such as RCC and UCC) develop in different ways, meaning that the diseases have different outlooks (or prognosis), and need to be staged and treated in different ways.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
The compound in the Mediterranean diet that makes cancer cells 'mortal'
New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...
Do salamanders hold the solution to regeneration?
Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...
Scientists identify molecular trigger for Alzheimer's disease
Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...
Practice makes perfect? Not so much
Turns out, that old "practice makes perfect" adage may be overblown. New research led by Michigan State University's Zach Hambrick finds that a copious amount of practice is not enough to explain why people ...
Older prostate cancer patients should think twice before undergoing treatment
Older prostate cancer patients with other underlying health conditions should think twice before committing to surgery or radiation therapy for their cancer, according to a multicenter study led by researchers in the UCLA ...
New test better detects elephantiasis worm infection
A new diagnostic test for a worm infection that can lead to severe enlargement and deformities of the legs and genitals is far more sensitive than the currently used test, according to results of a field ...
New immune system discovered
(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.
Researchers develop model for better testing, targeting of malignant peripheral nerve sheath tumors
University of Minnesota Medical School researchers from the Masonic Cancer Center, University of Minnesota, in partnership with the University's Brain Tumor Program, have developed a new mouse model of malignant peripheral ...
Study shows how bilinguals switch between languages
(Medical Xpress)—Individuals who learn two languages at an early age seem to switch back and forth between separate "sound systems" for each language, according to new research conducted at the University of Arizona.
Study suggests new source of kidneys for transplant
Nearly 20 percent of kidneys that are recovered from deceased donors in the U.S. are refused for transplant due to factors ranging from scarring in small blood vessels of the kidney's filtering units to the organ going too ...
